We are here to help
We are pleased to announce that ScanDroitin® has been approved as an Individually Recognized Functional Ingredient by the Ministry of Food and Drug Safety (MFDS) in South Korea. The approval has ben obtained by our Korean partner, Daehan Chemtech ...
Due to growing demand, ZPD A/S, located on H. E. Bluhmes Vej in Esbjerg, has approved a significant investment in its production of Chondroitin Sulfate for the prevention of osteoarthritis and joint pain. The project aims to enhance ZPD’s production ...
We are proud to announce that ZPD A/S has attained the acknowledged Chemical and TSE Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) ...
Subscribe to the ZPD newsletter and get the latest news on Chondroitin Sulfate and joint health.